Nav leads our Boston office and the innovation service line in our Strategy Practice. He is a leader in our Pharmaceutical & Medical Products Practice in North America and the McKinsey Center for Government’s work with regulatory agencies. He brings to his clients deep business expertise in innovation, strategy, operations, business development, and risk. An expert in the use of Six Sigma methodologies for product development and process design, Nav holds 15 patents.
Nav’s passions are at the intersection of science, engineering, medicine, and business. He works with pharmaceutical companies to help enhance their R&D productivity, with contract-research organizations to strengthen their performance, and with private-equity investors making investments in a variety of science- and medicine-intensive areas.
Nav also spearheads McKinsey’s knowledge initiatives on R&D productivity in the pharmaceutical industry, and leads our Center for Asset Optimization. He also hosts frequent Imagine events that convene cross-sector leaders on cutting-edge topics such as 3D printing, commercial applications of drones, and self-driving cars.
Among recent examples of his government work, Nav has helped regulators enhance their performance, and developed tools to help states optimize their IT portfolios.
Prior to joining McKinsey in 2001, Nav was a laboratory manager at General Electric, where he helped design manufacturing processes and develop new polymetric materials and nano-materials.
“What’s driving the surge in new drug approvals?” McKinsey & Company, November 2013
“Regulatory excellence,” McKinsey Center for Government compendium, October 2013
“New frontiers in pharma R&D investment,” McKinsey Quarterly, February 2010
|University of Minnesota
||PhD in chemical engineering
|Rensselaer Polytechnic University
|Indian Institute of Technology
||BTech in chemical engineering and engineering